Is It Time to Move Beyond Graft-Versus-Host Disease-Free, Relapse-Free Survival as a Primary End Point in Clinical Trials for Hematopoietic Cell Transplantation?

Journal of Clinical Oncology 2026

View at publisher

Authors: Amar H Kelkar, Gregory Alan Abel, Corey S Cutler, Stephanie J Lee, Robert J Soiffer

DOI: 10.1200/jco-25-02130

Cited by: 1

References: 51

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Acute Myeloid Leukemia Research Acute Lymphoblastic Leukemia research

References 51